Incentive Stock Programs

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Note 9 — Incentive Stock Programs

In the first three months of 2024, Abbott granted 1,666,566 stock options, 404,597 restricted stock awards and 5,189,560 restricted stock units under its incentive stock program. At March 31, 2024, approximately 60 million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at March 31, 2024 is as follows:


	Outstanding		Exercisable
Number of shares	28,281,501		24,296,425
Weighted average remaining life (years)	5.1		4.4
Weighted average exercise price	$	78.71	$	73.05
Aggregate intrinsic value (in millions)	$	1,031	$	1,020

The total unrecognized share-based compensation cost at March 31, 2024 amounted to approximately $787 million, which is expected to be recognized over the next three years.